Autoimmune pancreatitis laboratory findings: Difference between revisions

Jump to navigation Jump to search
Line 14: Line 14:
**Elevated serum alkaline phosphatase levels (ALP)
**Elevated serum alkaline phosphatase levels (ALP)
**Elevated serum aminotransferases
**Elevated serum aminotransferases
**ESR
**CA19-9


==References==
==References==

Revision as of 01:54, 19 December 2017

Autoimmune pancreatitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Autoimmune pancreatitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Autoimmune pancreatitis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Autoimmune pancreatitis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Autoimmune pancreatitis laboratory findings

CDC on Autoimmune pancreatitis laboratory findings

Autoimmune pancreatitis laboratory findings in the news

Blogs on Autoimmune pancreatitis laboratory findings

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Autoimmune pancreatitis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Laboratory Findings

  • Laboratory findings consistent with the diagnosis of autoimmune pancreatitis include:
    • Increased serum IgG4 levels (>2 times the upper limit of normal in most patients)
    • Other autoantibodies (ANA)
    • Rheumatoid factor (RF)
    • IgG4-positive plasma cells[1][2][3][4][5]
    • Elevated serum alkaline phosphatase levels (ALP)
    • Elevated serum aminotransferases
    • ESR
    • CA19-9

References

  1. Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, Okamoto A, Egawa N, Nakajima H (2003). "A new clinicopathological entity of IgG4-related autoimmune disease". J. Gastroenterol. 38 (10): 982–4. doi:10.1007/s00535-003-1175-y. PMID 14614606.
  2. Shinji A, Sano K, Hamano H, Unno H, Fukushima M, Nakamura N, Akamatsu T, Kawa S, Kiyosawa K (2004). "Autoimmune pancreatitis is closely associated with gastric ulcer presenting with abundant IgG4-bearing plasma cell infiltration". Gastrointest. Endosc. 59 (4): 506–11. PMID 15044886.
  3. Takeda S, Haratake J, Kasai T, Takaeda C, Takazakura E (2004). "IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis". Nephrol. Dial. Transplant. 19 (2): 474–6. PMID 14736977.
  4. Saeki T, Saito A, Hiura T, Yamazaki H, Emura I, Ueno M, Miyamura S, Gejyo F (2006). "Lymphoplasmacytic infiltration of multiple organs with immunoreactivity for IgG4: IgG4-related systemic disease". Intern. Med. 45 (3): 163–7. PMID 16508232.
  5. Umemura T, Zen Y, Hamano H, Kawa S, Nakanuma Y, Kiyosawa K (2007). "Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis". Hepatology. 46 (2): 463–71. doi:10.1002/hep.21700. PMID 17634963.

Template:WH Template:WS